Loading stock data...

AstraZeneca Pharma India Limited

NSE: ASTRAZEN BSE: ASTRAZEN

NSE
8,908.50 1.50 (0.02%)

Prev Close

8907

Open Price

8965

Volume

41,092

Today Low / High

8815 / 9067.5

52 WK Low / High

6150 / 10691

Range

8,463 - 9,354

BSE
8,871.70 -24.60 (-0.28%)

Prev Close

8896.3

Open Price

8948.6

Volume

2,123

Today Low / High

8816.5 / 9071.15

52 WK Low / High

6171.25 / 10653.05

Range

8,428 - 9,315

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 8908.5 (target range: 8,463 - 9,354), reflecting a change of 1.5 (0.01684069%). On the BSE, it is listed at 8871.7 (target range: 8,428 - 9,315), showing a change of -24.6 (-0.27652%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

30 Jun 8,965.00 -0.63%
27 Jun 8,781.00 1.43%
26 Jun 8,847.00 -1.11%
25 Jun 8,794.00 0.60%
24 Jun 8,963.00 -2.06%
23 Jun 8,868.50 0.08%
20 Jun 9,300.50 -4.62%
19 Jun 9,680.50 -2.79%
18 Jun 10,000.00 -2.66%
17 Jun 10,290.00 -2.15%
16 Jun 10,450.00 -1.76%
13 Jun 10,029.00 4.79%
12 Jun 9,960.00 2.36%
11 Jun 9,980.00 -0.10%
10 Jun 10,000.00 0.55%
09 Jun 9,900.00 1.59%
06 Jun 9,850.00 -0.61%
05 Jun 9,495.00 4.10%
04 Jun 9,250.00 2.63%
03 Jun 9,313.00 0.25%

AstraZeneca Pharma India Limited Graph

AstraZeneca Pharma India Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for AstraZeneca Pharma India Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 8,908.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 8,871.70 8,960.42 8,064.38 - 9,856.46
9,049.13 7,239.31 - 10,858.96
9,137.85 6,396.50 - 11,879.21
Bearish Scenario 8,871.70 8,782.98 7,904.68 - 9,661.28
8,694.27 6,955.41 - 10,433.12
8,605.55 6,023.88 - 11,187.21

Overview of AstraZeneca Pharma India Limited

ISIN

INE203A01020

Industry

Drug Manufacturers - Specialty & Generic

Vol.Avg

76,628

Market Cap

222,712,500,000

Last Dividend

24

Official Website

Visit Website

IPO Date

2002-07-01

DCF Diff

-4,564.72

DCF

13,473

Financial Ratios Every Investor Needs

Stock Dividend of ASTRAZEN

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2024-07-05 July 05, 24 24 24 2024-07-05 2024-09-06
2023-07-14 July 14, 23 16 16 2023-07-14 2023-09-13
2022-07-07 July 07, 22 8 8 2022-07-08 2022-09-06
2021-08-18 August 18, 21 2 2 2021-08-20 2021-09-07
2020-08-20 August 20, 20 2 2 2020-08-21 2020-09-08 2020-08-10

Stock Rating Details for ASTRAZEN

Metric Value Recommendation
Overall Rating B+ Neutral
DCF Score 4 Buy
ROE Score 4 Buy
ROA Score 5 Strong Buy
Debt-to-Equity (DE) Score 3 Neutral
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 1,716.29 Cr 963.01 Cr 753.28 Cr 0.4389 0.00 Cr 0.00 Cr 213.98 Cr 115.74 Cr 46.30 197.81 Cr 0.0674
2024-03-31 1,295.53 Cr 673.26 Cr 622.27 Cr 0.4803 0.00 Cr 42.15 Cr 171.43 Cr 161.51 Cr 64.60 235.68 Cr 0.1247
2023-03-31 1,002.97 Cr 425.26 Cr 577.71 Cr 0.5760 0.00 Cr 29.93 Cr 148.89 Cr 99.29 Cr 39.72 150.99 Cr 0.0990
2022-03-31 805.60 Cr 357.46 Cr 448.14 Cr 0.5563 0.00 Cr 28.00 Cr 69.65 Cr 61.60 Cr 24.64 100.94 Cr 0.0765
2021-03-31 808.56 Cr 330.54 Cr 478.02 Cr 0.5912 0.00 Cr 31.89 Cr 116.26 Cr 93.30 Cr 37.32 147.93 Cr 0.1154

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 536.14 Cr 1,518.12 Cr 747.77 Cr 770.3500 Cr 35.73 Cr -500.41 Cr 548.50 Cr 63.58 Cr 0.00 Cr 0.00 Cr 8.14 Cr 703.0000 Cr
2024-03-31 505.57 Cr 1,078.03 Cr 366.11 Cr 711.9200 Cr 4.59 Cr -500.98 Cr 227.88 Cr 64.84 Cr 49.61 Cr 0.00 Cr 0.00 Cr 357.1200 Cr
2023-03-31 500.34 Cr 984.87 Cr 396.20 Cr 588.6900 Cr 7.21 Cr -493.12 Cr 190.21 Cr 70.19 Cr 40.17 Cr 0.00 Cr 0.00 Cr 383.9300 Cr
2022-03-31 448.42 Cr 856.56 Cr 345.17 Cr 511.3900 Cr 8.63 Cr -439.79 Cr 140.22 Cr 76.69 Cr 30.69 Cr 0.00 Cr 0.00 Cr 332.6500 Cr
2021-03-31 352.34 Cr 774.71 Cr 318.54 Cr 456.1700 Cr 12.14 Cr -340.20 Cr 159.80 Cr 84.98 Cr 12.83 Cr 0.00 Cr 0.00 Cr 303.5000 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 65.3600 Cr 30.8000 Cr -65.5900 Cr 63.6100 Cr 30.5700 Cr 536.1400 Cr -1.7500 Cr 156.3600 Cr 0.0000 Cr -60.0000 Cr -320.6200 Cr
2024-03-31 27.8700 Cr 21.7400 Cr -44.3800 Cr 17.1100 Cr 5.2300 Cr 505.5700 Cr -10.7600 Cr 161.5100 Cr 0.0000 Cr -40.0000 Cr -37.6679 Cr
2023-03-31 58.2900 Cr 18.1100 Cr -24.4800 Cr 49.7700 Cr 51.9200 Cr 500.3400 Cr -8.5200 Cr 134.1000 Cr 0.0000 Cr -20.0000 Cr -49.9948 Cr
2022-03-31 100.8000 Cr 4.7400 Cr -9.4600 Cr 91.1800 Cr 96.0800 Cr 448.4200 Cr -9.6200 Cr 83.0400 Cr 0.0000 Cr -5.0000 Cr 19.5800 Cr
2021-03-31 104.7800 Cr 173.0300 Cr -8.9700 Cr 97.0700 Cr 268.8400 Cr 352.3400 Cr -7.7100 Cr 127.0900 Cr 0.0000 Cr -5.0000 Cr 5.3500 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 480.48 Cr 259.61 Cr 220.87 Cr 0.4597 68.68 Cr 58.25 Cr 23.30 96.84 Cr 0.1212
2024-12-31 440.29 Cr 247.03 Cr 193.26 Cr 0.4389 67.92 Cr 30.85 Cr 12.34 51.42 Cr 0.0701
2024-09-30 408.00 Cr 225.93 Cr 182.07 Cr 0.4463 43.20 Cr 38.43 Cr 15.37 60.69 Cr 0.0942
2024-06-30 387.52 Cr 295.31 Cr 92.21 Cr 0.2379 34.16 Cr -11.79 Cr -4.72 -11.14 Cr -0.0304
2024-03-31 383.20 Cr 275.29 Cr 107.91 Cr 0.2816 47.55 Cr 39.48 Cr 15.79 58.12 Cr 0.1030

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 536.14 Cr 16.36 Cr 552.50 Cr 185.18 Cr 548.50 Cr 1,342.35 Cr 63.58 Cr 1,518.12 Cr 747.77 Cr
2024-12-31 0.00 Cr 0.00 Cr 496.78 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -679.35 Cr
2024-09-30 496.52 Cr 11.45 Cr 507.97 Cr 150.09 Cr 381.99 Cr 1,066.53 Cr 67.46 Cr 1,241.30 Cr 561.95 Cr
2024-06-30 0.00 Cr 0.00 Cr 505.57 Cr 0.00 Cr 0.00 Cr 505.57 Cr 0.00 Cr 0.00 Cr -711.92 Cr
2024-03-31 505.57 Cr 2.47 Cr 505.84 Cr 153.13 Cr 227.88 Cr 932.71 Cr 64.84 Cr 1,078.03 Cr 366.11 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-12-31 30.85 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 38.43 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 -11.79 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 39.48 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 15.80 Cr 7.41 Cr 0.00 Cr 0.00 Cr 7.41 Cr 527.66 Cr 520.25 Cr 0.00 Cr 7.41 Cr

Splits History

Date Label Split Ratio
2006-06-15 June 15, 06 5:1

Similar Stocks: Drug Manufacturers - Specialty & Generic

Company Name Symbol Price Market Cap Volume
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,675.70 ₹4,020,473,496,000.00 ₹2,160,156.00
Divi's Laboratories Limited DIVISLAB ₹6,809.50 ₹1,807,711,155,500.00 ₹599,616.00
Torrent Pharmaceuticals Limited TORNTPHARM ₹3,408.20 ₹1,153,488,249,000.00 ₹2,210,812.00
Dr. Reddy's Laboratories Limited DRREDDY ₹1,283.30 ₹1,067,807,930,342.00 ₹2,224,032.00
Zydus Lifesciences Limited ZYDUSLIFE ₹989.95 ₹996,117,388,500.00 ₹818,641.00
Mankind Pharma Limited MANKIND ₹2,319.80 ₹957,448,177,448.00 ₹242,516.00
Lupin Limited LUPIN ₹1,938.00 ₹885,074,910,000.00 ₹747,405.00
Aurobindo Pharma Limited AUROPHARMA ₹1,134.80 ₹659,094,109,600.00 ₹1,653,538.00
Alkem Laboratories Limited ALKEM ₹4,939.00 ₹590,531,535,000.00 ₹71,581.00
Glenmark Pharmaceuticals Limited GLENMARK ₹1,753.80 ₹494,924,113,800.00 ₹925,570.00
Suven Pharmaceuticals Limited SUVENPHAR ₹1,078.00 ₹412,407,234,624.00 ₹1,177,218.00
Laurus Labs Limited LAURUSLABS ₹724.85 ₹390,877,537,050.00 ₹4,837,288.00
Cohance Lifesciences Limited COHANCE ₹967.90 ₹370,286,607,043.00 ₹533,262.00
Ipca Laboratories Limited IPCALAB ₹1,389.80 ₹352,597,819,200.00 ₹334,888.00
Ajanta Pharma Limited AJANTPHARM ₹2,574.10 ₹321,535,979,200.00 ₹131,475.00
Wockhardt Limited WOCKPHARMA ₹1,714.00 ₹278,489,006,000.00 ₹1,320,711.00
J. B. Chemicals & Pharmaceuticals Limited JBCHEPHARM ₹1,679.30 ₹262,069,878,700.00 ₹1,260,647.00
Piramal Enterprises Limited PEL ₹1,144.20 ₹259,364,967,600.00 ₹439,580.00
Eris Lifesciences Limited ERIS ₹1,683.80 ₹229,328,508,600.00 ₹146,873.00
AstraZeneca Pharma India Limited ASTRAZEN ₹8,908.50 ₹222,712,500,000.00 ₹41,092.00
Alembic Pharmaceuticals Limited APLLTD ₹1,039.10 ₹204,248,613,300.00 ₹15,274,048.00
Jubilant Pharmova Limited JUBLPHARMA ₹1,210.60 ₹192,825,578,600.00 ₹542,905.00
NATCO Pharma Limited NATCOPHARM ₹926.65 ₹165,972,281,500.00 ₹2,317,809.00
Caplin Point Laboratories Limited CAPLIPOINT ₹2,117.60 ₹160,962,375,920.00 ₹209,291.00
Neuland Laboratories Limited NEULANDLAB ₹12,000.00 ₹153,958,800,000.00 ₹31,199.00
Glenmark Life Sciences Limited GLS ₹1,086.00 ₹133,070,838,000.00 ₹130,938.00
Granules India Limited GRANULES ₹495.30 ₹120,181,573,200.00 ₹480,052.00
Procter & Gamble Health Limited PGHL ₹5,880.50 ₹97,612,771,700.00 ₹5,473.00
Shilpa Medicare Limited SHILPAMED ₹890.55 ₹87,087,685,995.00 ₹84,311.00
Strides Pharma Science Limited STAR ₹899.65 ₹82,914,173,055.00 ₹451,712.00
Aarti Pharmalabs Limited AARTIPHARM ₹890.35 ₹80,696,533,917.00 ₹509,474.00
FDC Limited FDC ₹487.50 ₹79,369,875,000.00 ₹123,391.00
Suven Life Sciences Limited SUVEN ₹246.15 ₹53,678,915,100.00 ₹185,211.00
Sun Pharma Advanced Research Company Limited SPARC ₹162.39 ₹52,699,127,580.00 ₹588,486.00
Innova Captab Limited INNOVACAP ₹858.75 ₹49,141,908,638.00 ₹33,627.00
Sequent Scientific Limited SEQUENT ₹192.75 ₹48,246,288,750.00 ₹444,510.00
Hikal Limited HIKAL ₹358.90 ₹44,252,728,900.00 ₹296,200.00
Aarti Drugs Limited AARTIDRUGS ₹458.15 ₹41,815,350,500.00 ₹289,887.00
Unichem Laboratories Limited UNICHEMLAB ₹589.30 ₹41,490,137,940.00 ₹13,357.00
RPG Life Sciences Limited RPGLIFE ₹2,480.80 ₹41,029,951,200.00 ₹30,790.00
Gufic Biosciences Limited GUFICBIO ₹364.05 ₹36,506,205,900.00 ₹138,450.00
Orchid Pharma Limited ORCHPHARMA ₹714.30 ₹36,228,653,130.00 ₹50,530.00
Morepen Laboratories Limited MOREPENLAB ₹61.77 ₹33,847,118,580.00 ₹4,023,013.00
Alembic Limited ALEMBICLTD ₹121.80 ₹31,276,047,478.00 ₹6,054,805.00
Solara Active Pharma Sciences Limited SOLARA ₹637.05 ₹30,675,868,650.00 ₹262,587.00
Indoco Remedies Limited INDOCO ₹317.60 ₹29,297,933,040.00 ₹135,261.00
IOL Chemicals and Pharmaceuticals Limited IOLCP ₹97.19 ₹28,527,889,130.00 ₹1,241,703.00

Key Executives

Vice President of Human Resources
Ms. Smita Saha

Gender: female

Year Born: 1970

Interim Business Unit Head of Oncology & Director of Commercial Excellence
Mr. Ayush Kumar Agarwal

Gender: male

Year Born:

Legal Counsel
Mr. Pratap Rudra Bhuvanagiri

Gender: male

Year Born:

Legal Head
Mr. Pankaj S Jain

Gender: male

Year Born:

Head of Oncology Business Unit
Mr. Praveen Akkinepally

Gender: male

Year Born:

Company Secretary & Compliance Officer
Ms. Manasa R.

Gender: female

Year Born:

Business Unit Head - Rare Disease unit
Mr. Vinay Sharma

Gender: male

Year Born:

Whole-Time Director & Chief Financial Officer
Ms. Bhavana Agrawal

Gender: female

Year Born:

MD, Country President & Director
Dr. Sanjeev Kumar Panchal

Gender: Not Specified

Year Born: 1977

FAQs about AstraZeneca Pharma India Limited

Who is the CEO of the company?

The CEO is Sanjeev Kumar Panchal.

What is the current market price of the stock?

The current price is ₹8,908.50.

What is the 52-week price range?

The range is ₹6150-10691.

What is the market capitalization of the company?

The market capitalization is ₹22,271.25 crores.

What is the dividend yield?

The dividend yield is 0.27%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 192.41.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of AstraZeneca Pharma India Limited (ISIN: INE203A01020) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹22,271.25 crores and an average daily volume of 76,628 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹24.